Biotronik Ag
Clinical trials sponsored by Biotronik Ag, explained in plain language.
-
New dissolving heart stent aims to clear long blockages
Disease control Recruiting nowThis study is testing the safety and performance of a new, longer version of a dissolvable heart stent called Freesolve. The stent is placed in blocked heart arteries to improve blood flow, slowly releases a medicine to prevent re-narrowing, and is designed to dissolve over time.…
Phase: NA • Sponsor: Biotronik AG • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Dissolving stents get Real-World test in over 1,100 patients
Disease control Recruiting nowThis study is tracking how well dissolvable magnesium stents work in everyday medical practice for people with clogged heart arteries. It will follow over 1,100 patients for one year to see if the stent area needs repeat treatment or causes serious heart problems. The goal is to …
Sponsor: Biotronik AG • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Breakthrough heart stent trial: dissolving device aims to outperform metal
Disease control Recruiting nowThis study is testing a new type of heart stent called Freesolve, which is made of magnesium and dissolves over time. It is being compared to a standard, permanent metal drug-coated stent (Xience) in 1,859 patients with blocked heart arteries. The main goal is to see if the disso…
Phase: NA • Sponsor: Biotronik AG • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC